Spatially resolved transcriptomics reveals a unique disease signature and potential biomarkers for chronic traumatic encephalopathy
Journal of Neuropathology & Experimental Neurology · 01.11.2025 · 84 (11) · 967-977
DOI: 10.1093/jnen/nlaf078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 18.07.2025. Verfasst von Catherine M Suter und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, University of Sydney, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Chronic Traumatic Encephalopathy, Transcriptome, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Adult Changes in Thought Study, UW Alzheimer's Disease Research Center, Australian Sports Brain Bank.
Abstract (Originalsprache)
Chronic traumatic encephalopathy (CTE) is a poorly understood environmental tauopathy uniquely associated with repetitive head injury. It is clinically ambiguous and at present can only be diagnosed post-mortem. There is a pressing need to understand CTE pathophysiology in order to identify targets for possible intervention and biomarkers for in-life diagnosis. However, molecular characterization of the disease is hampered by the stochastic distribution of CTE lesions. Here, we have taken advantage of Visium spatial transcriptomics to map gene expression in discrete CTE lesions and matched normal tissue from the same individuals. In doing so, we derived a common 21-gene “signature” of CTE lesions that highlights astrocytic activation, neuroinflammation, blood-brain barrier function, and extracellular matrix remodeling as key features of CTE lesions. Almost all CTE signature genes were strongly expressed in astrocytes and ontological and protein association analyses implicated extracellular matrix functions as drivers of the disease. These findings provide the first glimpse into the intricate molecular dynamics underlying CTE lesions in situ and present 21 candidate molecules for the development of in-life CTE diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Sciences, University of Sydney, Sydney, NSW, Australia.
- Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
- Westmead Research Hub, Westmead Institute for Medical Research, Westmead, NSW, Australia.
ORCID-Profile: Catherine M Suter
Förderung
- Adult Changes in Thought Study
- UW Alzheimer's Disease Research Center
- Australian Sports Brain Bank
- NIA NIH HHS
- NIH
- Sydney Local Health District
Zitieren
APA
Suter, C. M., Cropley, J. E., Affleck, A. J., Lee, M., Hammond, K., Gloss, B., & Buckland, M. E. (2025). Spatially resolved transcriptomics reveals a unique disease signature and potential biomarkers for chronic traumatic encephalopathy. Journal of Neuropathology & Experimental Neurology, 84(11), 967-977. https://doi.org/10.1093/jnen/nlaf078
Vancouver
Suter CM, Cropley JE, Affleck AJ, Lee M, Hammond K, Gloss B, et al. Spatially resolved transcriptomics reveals a unique disease signature and potential biomarkers for chronic traumatic encephalopathy. Journal of Neuropathology & Experimental Neurology. 2025;84(11):967-977. doi:10.1093/jnen/nlaf078
BibTeX
@article{Suter2025,
author = {Suter, Catherine M and Cropley, Jennifer E and Affleck, Andrew J and Lee, Maggie and Hammond, Karina and Gloss, Brian and Buckland, Michael E},
title = {Spatially resolved transcriptomics reveals a unique disease signature and potential biomarkers for chronic traumatic encephalopathy},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2025},
volume = {84},
number = {11},
pages = {967--977},
doi = {10.1093/jnen/nlaf078}
}
EUVIMED